Review The SDS Document
DOWNLOADProduct Details
Formula
C17H12Br2O3
MW
424.09
Purity
>97%
Solubility (DMSO Mg/MI)
39
Bio Chemical Notes
Benzbromarone was first introduced for the treatment of gout in the 1970's, is a uricosuric agent and non-competitive inhibitor of xanthine oxidase. In 2003 the drug was withdrawn due to reports of serious hepatotoxicity. Also acts as a potent inhibitor of CYP2C9 enzyme. Ref: Drug Safety 2008; 31 (8); 643-665.